DE3273628D1 - Phosphonamidate compounds - Google Patents

Phosphonamidate compounds

Info

Publication number
DE3273628D1
DE3273628D1 DE8282401459T DE3273628T DE3273628D1 DE 3273628 D1 DE3273628 D1 DE 3273628D1 DE 8282401459 T DE8282401459 T DE 8282401459T DE 3273628 T DE3273628 T DE 3273628T DE 3273628 D1 DE3273628 D1 DE 3273628D1
Authority
DE
Germany
Prior art keywords
phosphonamidate
phosphonamidate compounds
compounds
useful
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282401459T
Other languages
German (de)
English (en)
Inventor
Donald S Karanewski
Edward W Petrillo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of DE3273628D1 publication Critical patent/DE3273628D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/44Amides thereof
    • C07F9/4461Amides thereof the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4465Amides thereof the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/18Stationary reactors having moving elements inside
    • B01J19/1806Stationary reactors having moving elements inside resulting in a turbulent flow of the reactants, such as in centrifugal-type reactors, or having a high Reynolds-number
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568Four-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8282401459T 1981-08-03 1982-08-03 Phosphonamidate compounds Expired DE3273628D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28967181A 1981-08-03 1981-08-03

Publications (1)

Publication Number Publication Date
DE3273628D1 true DE3273628D1 (en) 1986-11-13

Family

ID=23112565

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282401459T Expired DE3273628D1 (en) 1981-08-03 1982-08-03 Phosphonamidate compounds

Country Status (5)

Country Link
EP (1) EP0071544B1 (enExample)
JP (1) JPS5838294A (enExample)
AT (1) ATE22692T1 (enExample)
CA (1) CA1276392C (enExample)
DE (1) DE3273628D1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8866782A (en) * 1981-09-25 1983-03-31 Wellcome Foundation Limited, The N-phosphorous-dipeptides
JPS58217319A (ja) * 1982-06-11 1983-12-17 Idemitsu Petrochem Co Ltd 非極性合成樹脂フイルムの溶着方法
NZ225757A (en) * 1987-09-10 1989-12-21 Squibb & Sons Inc Phosphonate and phosphonamide endopeptidase inhibitors
US4849525A (en) * 1987-09-21 1989-07-18 E. R. Squibb & Sons, Inc. Phosphinylcycloalkylcarbonyl and phosphinylcycloalkenylcarbonyl dipeptides
US5504080A (en) * 1992-10-28 1996-04-02 Bristol-Myers Squibb Co. Benzo-fused lactams
IT1276161B1 (it) * 1995-11-23 1997-10-27 Zambon Spa Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi
WO2007078990A2 (en) 2005-12-23 2007-07-12 Zealand Pharma A/S Modified lysine-mimetic compounds
PL2468724T3 (pl) 2006-12-21 2016-05-31 Zealand Pharma As Synteza związków pirolidynowych
WO2017055193A1 (de) * 2015-09-29 2017-04-06 Bayer Cropscience Aktiengesellschaft Verfahren zur Herstellung von Phosphinaten
US11324799B2 (en) 2017-05-05 2022-05-10 Zealand Pharma A/S Gap junction intercellular communication modulators and their use for the treatment of diabetic eye disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316896A (en) * 1978-09-07 1982-02-23 Merck & Co., Inc. Aminoacid derivatives as antihypertensives
US4379146A (en) * 1981-02-17 1983-04-05 Merck & Co., Inc. Substituted phosphonamides as antihypertensives

Also Published As

Publication number Publication date
JPH0354116B2 (enExample) 1991-08-19
ATE22692T1 (de) 1986-10-15
JPS5838294A (ja) 1983-03-05
CA1276392C (en) 1990-11-13
EP0071544B1 (en) 1986-10-08
EP0071544A1 (en) 1983-02-09

Similar Documents

Publication Publication Date Title
EP0097534A3 (en) Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
DE3865817D1 (enExample)
IE823045L (en) Amino acid derivatives containing phosphorus
EP0857718A4 (en) ENDOTHELIN ANTAGONIST
ATE57613T1 (de) Orale zusammensetzungen.
AR244667A1 (es) Procedimiento para preparar un compuesto de n-benzoil urea.
IL109901A (en) Peptidic phosphinyloxymethyl ketones and pharmaceutical compositions containing them
DE3273628D1 (en) Phosphonamidate compounds
MA20919A1 (fr) Procede de preparation d'inhibiteurs de l'enzyme de conversion de l'angiotensine
IN164615B (enExample)
IT8422150A0 (it) Composti dotati di attivita'antiallergica.
ES8602021A1 (es) Procedimiento de preparar compuestos espirociclicos antihi- pertensivos
IE813100L (en) Naphthyridine derivatives
IL77009A0 (en) Biphenylyloxy and biphenylylalkoxy aryl acyl urea derivatives,processes for the preparation thereof and pesticidal compositions containing the same
GR862285B (en) Pharmaceutical compositions for treating the high blood pressure
ES8506661A1 (es) Procedimiento para la preparacion de un nuevo derivado de 2-tolil-morfolina util en terapeutica
IT8519903A0 (it) Farmaceutiche che li contengono. composti ad attivita'antiaggregante piastrinica, procedimento per la loro preparazione e composizioni
EP0127090A3 (en) Angiotensin-converting enzyme inhibitors
UA26981A1 (uk) Гербіцидhа композиція
ES8606874A1 (es) Metodo de preparacion de compuestos espiroamidoamino anti- hipertensivos
EP0153755A3 (en) Compounds for treating hypertension
IT8419682A0 (it) Composti ad attivita'ipolipemizzante.
DE3360845D1 (en) Immunomodulators containing as the active ingredient alpha-benzyl malic acid
IT8421856A0 (it) Composto chimico ad attivita'diuretica, antiipertensiva.
IT8720589A0 (it) Composti di attivita' nootropa.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee